Anti-neoplastic compositions and uses thereof
US6521602B1 · kind B1 · utility
13Cited by
1References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 1, 2000 |
| Grant date | Feb 18, 2003 |
| Priority date | — |
| Expiry date | Mar 1, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/60
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a nucleic acid composition consisting essentially of a first nucleic acid sequence encoding a chimeric CDKi protein and a second nudeic acid sequence encoding an adenovirus E4 protein, wherein the first and second nucleic acid sequences are operably linked to at least one regulatory sequence.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.